Abstract
In pharmaceutical industries, various chemical carriers are present which are used for drug delivery to the correct target sites. The most popular and upcoming drug delivery carriers are mesoporous silica nanoparticles (MSN). The main reason for its popularity is its ability to be specific and optimize the drug delivery process in a controlled manner. Nowadays, MSNs are widely used to eradicate various microbial infections, especially the ones related to biofilms. Biofilms are sessile groups of cells that live by forming a consortium and exhibit antibacterial resistance (AMR). They exhibit AMR by extracellular polymeric substances (EPS) and various quorum sensing (QS) signaling molecules. Usually, bacterial and fungal cells are capable of forming biofilms. These biofilms are pathogenic. In the majority of the cases, biofilms cause nosocomial diseases. This review will focus on the antibiofilm activities of MSN, its mechanism of target-specific drug delivery, and its ability to disrupt the bacterial biofilms inhibiting the infection. The review will also discuss various mechanisms for the delivery of pharmaceutical molecules by the MSNs to inhibit the bacterial biofilms, and lastly, we will talk about the different types of MSNs and their antibiofilm activities.
Similar content being viewed by others
Availability of data and materials
Not applicable.
References
Abo-zeid Y, Williams GR (2020) The potential anti-infective applications of metal oxide nanoparticles: a systematic review. Wiley Interdiscip Rev Nanomed Nanobiotechnol 12(2):1–36. https://doi.org/10.1002/wnan.1592
Ahmadi E, Dehghannejad N, Hashemikia S, Ghasemnejad M, Tabebordbar H (2014) Synthesis and surface modification of mesoporous silica nanoparticles and its application as carriers for sustained drug delivery. Drug Deliv 21(3):164–172. https://doi.org/10.3109/10717544.2013.838715
Araújo LAD, Addor F, Campos PMBGM (2016) Use of silicon for skin and hair care: an approach of chemical forms available and efficacy. An Bras Dermatol 91:0331–0335
Arciola CR, Campoccia D, Montanaro L (2018) Implant infections: adhesion, biofilm formation and immune evasion. Nat Rev Microbiol 16:397–409
Arias LS, Pessan JP, Vieira APM, Tmt DL, Delbem ACB, Monteiro DR (2018) Iron oxide nanoparticles for biomedical applications: a perspective on synthesis, drugs, antimicrobial activity, and toxicity. Antibiotics. 7:2. https://doi.org/10.3390/antibiotics7020046
Bai Y-M, Mao J, Xiong LD et al (2019) Bimodal antibacterial system based on quaternary ammonium silane-coupled core-shell hollow mesoporous silica. Acta Biomater 85:229–240. https://doi.org/10.1016/j.actbio.2018.12.037
Bai Y, An N, Chen D, Liu YZ, Liu CP, Yao H, Wang C, Song X, Tian W (2020) Facile construction of shape-regulated βcyclodextrin-based supramolecular self-assemblies for drug delivery. Carbohydr Polym 231:115714
Balaure PC, Boarca B, Popescu RC et al (2017) Bioactive mesoporous silica nanostructures with anti-microbial and anti-biofilm properties. Int J Pharm 531(1):35–46. https://doi.org/10.1016/j.ijpharm.2017.08.062
Barani M, Paknia F, Roostaee M, Kavyani B, Kalantar-Neyestanaki D, Ajalli N, Amirbeigi A (2023) Niosome as an effective nanoscale solution for the treatment of microbial infections. Biomed Res Int 2023:9933283, 18 pages. https://doi.org/10.1155/2023/9933283
Bardbari AM, Arabestani MR, Karami M, Keramat F, Aghazadeh H, Alikhani MY, Bagheri KP (2018) Highly synergistic activity of melittin with imipenem and colistin in biofilm inhibition against multidrug-resistant strong biofilm producer strains of Acinetobacter Baumannii. Eur J Clin Microbiol Infect Dis 37:443–454
Benezra M, Penate-Medina O, Zanzonico PB, Schaer D, Ow H, Burns A, ... Bradbury MS (2011) Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. J Clin Investig 121(7):2768–2780
Bernardos A, Piacenza E, Sancenón F, Hamidi M, Maleki A, Turner RJ, Martínez-Máñez R (2019) Mesoporous silica-based materials with bactericidal properties. Small. 15:1900669. https://doi.org/10.1002/smll.201900669
Bharti C, Nagaich U, Pal AK, Gulati N (2015) Mesoporous silica nanoparticles in target drug delivery system: A review. Int J Pharm Investig 5(3):124–33. https://doi.org/10.4103/2230-973X.160844
Braun K, Pochert A, Lindén M et al (2016) Membrane interactions of mesoporous silica nanoparticles as carriers of antimicrobial peptides. J Colloid Interface Sci 475:161–170. https://doi.org/10.1016/j.jcis.2016.05.002
Budimir M, Jijie R, Ye R, Barras A, Melinte S, Silhanek A, Markovic Z, Szunerits S, Boukherroub R (2019) Efficient capture and photothermal ablation of planktonic bacteria and biofilms using reduced graphene oxide−polyethyleneimine flexible nanoheaters. J Mater Chem B 7:2771–2781
Bukara K, Schueller L, Rosier J, Martens MA, Daems T, Verheyden L, Eelen S, Van Speybroeck M, Libanati C, Martens JA, Van Den Mooter G, Fre´rart F, Jolling K, De Gieter M, Bugarski B, Kiekens F (2016) Eur J Pharm Biopharm 108:220–225
Burns AA, Vider J, Ow H, Herz E, Penate-Medina O, Baumgart M, ... Bradbury M (2009) Fluorescent silica nanoparticles with efficient urinary excretion for nanomedicine. Nano Lett 9(1):442–448
Carvalho GC, Sábio RM, de Cássia Ribeiro T, Monteiro AS, Pereira DV, Ribeiro SJL, Chorilli M (2020) Highlights in mesoporous silica nanoparticles as a multifunctional controlled drug delivery nanoplatform for infectious diseases treatment. Pharm Res 37:191. https://doi.org/10.1007/s11095-020-02917-6
Castillo RR, Vallet-Regí M (2021) Recent advances toward the use of mesoporous silica nanoparticles for the treatment of bacterial infections. Int J Nanomed 16:4409–4430. https://doi.org/10.2147/IJN.S273064
Chang Z-M, Wang Z, MengLu M et al (2017) Janus silver mesoporous silica nanobullets with synergistic antibacterial functions. Colloids Surf B Biointerfaces 157:199–206. https://doi.org/10.1016/j.colsurfb.2017.05.079
Chen Y, Chen H, Shi J (2013) In vivo bio-safety evaluations and diagnostic/therapeutic applications of chemically designed mesoporous silica nanoparticles. Adv Mater 25(23):3144–3176
Chen X, Liu Y, Lin A et al (2018) Folic acid-modified mesoporous silica nanoparticles with pH-responsiveness loaded with Amp for an enhanced effect against anti-drug-resistant bacteria by overcoming efflux pump systems. Biomater Sci 6(7):1923–1935. https://doi.org/10.1039/c8bm00262b
Chen W, Glackin CA, Horwitz MA, Zink JI (2019) Nanomachines and other caps on mesoporous silica nanoparticles for drug delivery. Acc Chem Res 52:1531–1542
Chen X, Xu C, He H (2019) Electrospinning of silica nanoparticles-entrapped nanofibers for sustained gentamicin release. Biochem Biophys Res Commun 516(4):1085–1089. https://doi.org/10.1016/j.bbrc.2019.06.163
Chen W, Cheng CA, Zink JI (2019) Spatial, temporal, and dose control of drug delivery using noninvasive magnetic stimulation. ACS Nano 13:1292–1308
Chen F, Nayak TR, Goel S, Valdovinos HF, Hong H, Theuer CP, … Cai W (2014) In vivo tumor vasculature targeted PET/NIRF imaging with TRC105(Fab)‐conjugated, dual‐labeled mesoporous silica nanoparticles. Mol Pharm 11(11):4007–4014. https://doi.org/10.1021/mp500306k
Chen L, Liu J, Zhang Y, Zhang G, Kang Y, Chen A, … Shao L (2018) The toxicity of silica nanoparticles to the immune system. Nanomedicine (London, England) 13(15):1939–1962. https://doi.org/10.2217/nnm-2018-0076
Chen H, Shen Z, Wu P et al (2020) Long effective tea tree oil/mesoporous silica sustained release system decorated by polyethyleneimine with high antibacterial performance. J Dispers Sci Technol 42(10):1448–1459. https://doi.org/10.1080/01932691.2020.1772816
Cheng G, Zhang Z, Chen S, Bryers JD, Jiang S (2007) Inhibition of bacterial adhesion and biofilm formation on zwitterionic surfaces. Biomaterials 28(29):4192–4199. https://doi.org/10.1016/j.biomaterials.2007.05.041
Cheng Y, Zhang Y, Deng W, Hu J (2020) Antibacterial and anticancer activities of asymmetric lollipop-like mesoporous silica nanoparticles loaded with curcumin and gentamicin sulfate. Colloids Surf B Biointerfaces 186:110744. https://doi.org/10.1016/j.colsurfb.2019.110744
Chircov C, Spoială A, Păun C, Crăciun L, Ficai D, Ficai A, ... Turculeƫ ȘC (2020) Mesoporous silica platforms with potential applications in release and adsorption of active agents. Molecules 25(17):3814
Choi J, Burns AA, Williams RM, Zhou Z, Flesken-Nikitin A, Zipfel WR, ... Nikitin AY (2007) Core-shell silica nanoparticles as fluorescent labels for nanomedicine. J Biomed Opt 12(6):064007
Chou TC (2010) Drug combination studies and their synergy quantification using the Chou-Talalay Method. Cancer Res 70:440–446
Colilla M, Vallet-Regí M (2020) Targeted stimuli-responsive mesoporous silica nanoparticles for bacterial infection treatment. Int J Mol Sci 21:8605. https://doi.org/10.3390/ijms21228605
de Azevedo M, Oliveira LF, Teles da Silva LV et al (2020) Antioxidant and antimicrobial activity of red propolis embedded mesoporous silica nanoparticles. Drug Dev Ind Pharm 46(7):1199–1208. https://doi.org/10.1080/03639045.2020.1782423
Deslouches B, Steckbeck JD, Craigo JK, Doi Y, Burns JL, Montelaro RC (2015) Engineered cationic antimicrobial peptides to overcome multidrug resistance by ESKAPE pathogens. Antimicrob Agents Chemother 59:1329–1333
Dinali R, Ebrahiminezhad A, Manley-Harris M, Ghasemi Y, Berenjian A (2017) Iron oxide nanoparticles in modern microbiology and biotechnology. Crit Rev Microbiol 43(4):493–507. https://doi.org/10.1080/1040841X.2016.1267708
Duan X, Xiao J, Yin Q, Zhang Z, Yu H, Mao S, Li Y (2013) Smart pH-sensitive and temporal-controlled polymeric micelles for effective combination therapy of doxorubicin and disulfiram. ACS Nano 7:5858–5869
Durack E, Mallen S, O’Connor PM et al (2019) Protecting bactofencin A to enable its antimicrobial activity using mesoporous matrices. Int J Pharm 558(December2018):9–17. https://doi.org/10.1016/j.ijpharm.2018.12.035
EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS), Younes M, Aggett P, Aguilar F, Crebelli R, Dusemund B, ... Lambré C (2018) Re‐evaluation of silicon dioxide (E 551) as a food additive. EFSA J 16(1):e05088
Encinas N, Angulo M, Astorga C, Colilla M, Izquierdo-Barba I, Vallet-Regí M (2019) Mixed-charge pseudo-zwitterionic mesoporous silica nanoparticles with low-fouling and reduced cell uptake properties. Acta Biomater 84:317–327. https://doi.org/10.1016/j.actbio.2018.12.012
Fischbach MA, Walsh CT (2009) Antibiotics for emerging pathogens. Science 325:1089–1093
Flemming HC, Wingender J (2010) The biofilm matrix. Nat Rev Microbiol 8:623–633
Gao Y, Chen Y, Ji X, He X, Yin Q, Zhang Z, Shi J, Li Y (2011) Controlled intracellular release of doxorubicin in multidrug-resistant cancer cells by tuning the shell-pore sizes of mesoporous silica nanoparticles. ACS Nano 5:9788–9798
Gao F, Zhou H, Shen Z et al (2020) Synergistic antimicrobial activities of tea tree oil loaded on mesoporous silica encapsulated by polyethyleneimine. J Dispers Sci Technol 41(12):1859–1871. https://doi.org/10.1080/01932691.2019.1637755
Gao L, Li M, Ehrmann S, Tu Z, Haag R (2019) Positively charged nanoaggregates based on zwitterionic pillar [5] arene that combat planktonic bacteria and disrupt biofilms. Angew Chem Int Ed 58:3645−3649
Geilich BM, Gelfat I, Sridhar S, van de Ven AL, Webster TJ (2017) Superparamagnetic iron oxide-encapsulating polymersome nanocarriers for biofilm eradication. Biomaterials 119:78–85
Ghaseminezhad SM, Shojaosadati SA, Meyer RL (2018) Ag/ Fe3O4 nanocomposites penetrate and eradicate s. aureus biofilm in an in vitro chronic wound model. Colloids Surf B 163:192−200
Gimenez C, de la Torre C, Gorbe M, Aznar E, Sancenon F, Murguia JR, … Amoros P (2015) Gated mesoporous silica nanoparticles for the controlled delivery of drugs in cancer cells. Langmuir 31(12):3753–3762. https://doi.org/10.1021/acs.langmuir.5b00139
Giri S, Trewyn BG, Stellmaker MP, Lin VS (2005) Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles. Angew Chem (Int Ed Engl) 44(32):5038–5044. https://doi.org/10.1002/anie.200501819
Gisbert-Garzarán M, Manzano M, Vallet-Regí M (2020) Mesoporous silica nanoparticles for the treatment of complex bone diseases: bone cancer, bone infection and osteoporosis. Pharmaceutics 12:83. https://doi.org/10.3390/pharmaceutics12010083
Gonzalez B, Colilla M, Diez J, Pedraza D, Guembe M, Izquierdo-Barba I, Vallet-Regi M (2018) Mesoporous silica nanoparticles decorated with polycationic dendrimers for infection treatment. Acta Biomater 68:261–271. https://doi.org/10.1016/j.actbio.2017.12.041
González B, Colilla M, Díez J et al (2018) Mesoporous silica nanoparticles decorated with polycationic dendrimers for infection treatment. Acta Biomater 68:261–271. https://doi.org/10.1016/j.actbio.2017.12.041
Gounani Z, Asadollahi MA, Pedersen JN et al (2019) Mesoporous silica nanoparticles carrying multiple antibiotics provide enhanced synergistic effect and improved biocompatibility. Colloids Surf B Biointerfaces 175:498–508. https://doi.org/10.1016/j.colsurfb.2018.12.035
Greco O, Folkes LK, Wardman P, Tozer GM, Dachs GU (2000) Development of a novel enzyme/prodrug combination for gene therapy of cancer: horseradish peroxidase/indole-3-acetic acid. Cancer Gene Ther 7(11):1414–1420. https://doi.org/10.1038/sj.cgt.7700258
Green DL, Lin JS, Lam Y-F, Hu MZC, Schaefer DW, Harris MT (2003) Size, volume fraction, and nucleation of Stober silica nanoparticles. J Colloid Interface Sci 266(2):346–358. https://doi.org/10.1016/s0021-9797(03)00610-6
Grün M, Lauer I, Unger KK (1997) The synthesis of micrometer- and submicrometer-size spheres of ordered mesoporous oxide MCM-41. Adv Mater 9(3):254–257. https://doi.org/10.1002/adma.19970090317
Hachemaoui M, Boukoussa B, Mokhtar A et al (2020) Dyes adsorption, antifungal and antibacterial properties of metal loaded mesoporous silica: effect of metal and calcination treatment. Mater Chem Phys 256:123704. https://doi.org/10.1016/j.matchemphys.2020.123704
Hadipour Moghaddam SP, Mohammadpour R, Ghandehari H (2019) In vitro and in vivo evaluation of degradation, toxicity, biodistribution, and clearance of silica nanoparticles as a function of size, porosity, density, and composition. J Control Release 311–312:1–15. https://doi.org/10.1016/j.jconrel.2019.08.028
Hakkarainen B, Fujita K, Immel S, Kenne L, Sandström C (2005) 1H NMR studies on the hydrogen-bonding network in mono-Altroβ-cyclodextrin and its complex with adamantane-1-carboxylic acid. Carbohydr Res 340:1539–1545
Han L, Tang C, Yin C (2015) Dual-targeting and pH/redox responsive multi-layered nanocomplexes for smart co-delivery of doxorubicin and SiRNA. Biomaterials 60:42–52
Hao N, Li L, Tang F (2014) Shape-mediated biological effects of mesoporous silica nanoparticles. J Biomed Nanotechnol 10(10):2508–2538. https://doi.org/10.1166/jbn.2014.1940
Høiby N, Ciofu O, Johansen HK, Song ZJ, Moser C, Jensen PØ, Givskov M, Tolker-Nielsen T, Bjarnsholt T (2011) The clinical impact of bacterial biofilms. Int J Oral Sci 3:55–65
Hwang G, Paula AJ, Hunter EE, Liu Y, Babeer A, Karabucak B, Stebe K, Kumar V, Steager E, Koo H (2019) Catalytic antimicrobial robots for biofilm eradication. Sci Robot 4:eaaw2388
Izquierdo-Barba I, Sánchez-Salcedo S, Colilla M et al (2011) Inhibition of bacterial adhesion on biocompatible zwitterionic SBA-15 mesoporous materials. Acta Biomater 7(7):2977–2985. https://doi.org/10.1016/j.actbio.2011.03.005
Jeelani PG, Mulay P, Venkat R, Ramalingam C (2019) Multifaceted application of silica nanoparticles. A review. Silicon. https://doi.org/10.1007/s12633-019-00229-y
Ji F, Sun H, Qin Z et al (2018) Engineering polyzwitterion and polydopamine decorated doxorubicin-loaded mesoporous silica nanoparticles as a pH-sensitive drug delivery. Polymers (Basel) 10(3):1–17. https://doi.org/10.3390/polym10030326
Jiménez-Jiménez C, Manzano M, Vallet-Regí M (2020) Nanoparticles coated with cell membranes for biomedical applications. Biology (Basel) 9:406. https://doi.org/10.3390/biology9110406
Kim IY, Joachim E, Choi H, Kim K (2015) Toxicity of silica nanoparticles depends on size, dose, and cell type. Nanomedicine 11(6):1407–1416. https://doi.org/10.1016/j.nano.2015.03.004
Kim JH, Kim CS, Ignacio RM, Kim DH, Sajo ME, Maeng EH, … Kim SK (2014) Immunotoxicity of silicon dioxide nanoparticles with different sizes and electrostatic charge. Int J Nanomed 9(Suppl. 2):183–193. https://doi.org/10.2147/ijn.S57934
Knowles BR, Wagner P, Maclaughlin S, Higgins MJ, Molino PJ (2017) Silica nanoparticles functionalized with zwitterionic sulfobetaine siloxane for application as a versatile antifouling coating system. ACS Appl Mater Interfaces 9(22):18584–18594. https://doi.org/10.1021/acsami.7b04840
Koo H, Allan RN, Howlin RP, Stoodley P, Hall-Stoodley L (2017) Targeting microbial biofilms: current and prospective therapeutic strategies. Nat Rev Microbiol 15:740–755
Koppen BC, Mulder PP, de Boer L, Riool M, Drijfhout JW, Zaat SA (2019) Synergistic microbicidal effect of cationic antimicrobial peptides and teicoplanin against planktonic and biofilm-encased Staphylococcus Aureus. Int J Antimicrob Agents 53:143–151
Kuthati Y, Kankala RK, Lin SX, Weng CF, Lee CH (2015) pH- Triggered Controllable release of silver-Indole-3 acetic acid complexes from mesoporous silica nanoparticles (IBN-4) for effectively killing malignant bacteria. Mol Pharm 12(7):2289–2304. https://doi.org/10.1021/mp500836w
Lee W, Kim K-J, Lee DG (2014) A novel mechanism for the antibacterial effect of silver nanoparticles on Escherichia coli. BioMetals 27(6):1191–1201. https://doi.org/10.1007/s10534-014-9782-z80
Leng D, Li Y, Zhu J et al (2020) The antibiofilm activity and mechanism of nanosilver- and nanozinc-incorporated mesoporous calcium-silicate nanoparticles. Int J Nanomed 15:3921–3936. https://doi.org/10.2147/IJN.S244686
Li L, Wang H (2013) Enzyme-coated mesoporous silica nanoparticles as efficient antibacterial agents in vivo. Adv Healthc Mater 2(10):1351–1360. https://doi.org/10.1002/adhm.201300051
Liao C, Li Y, Bactericidal TS (2019) Cytotoxic properties of silver nanoparticles. Int J Mol Sci 20(2):449. https://doi.org/10.3390/ijms20020449
Liong M, France B, Bradley KA, Zink JI (2009) Antimicrobial activity of silver nanocrystals encapsulated in mesoporous silica nanoparticles. Adv Mater 21(17):1684–1689. https://doi.org/10.1002/adma.200802646
Liu X, Shao W, Zheng Y, Yao C, Peng L, Zhang D, Hu XY, Wang L (2017) GSH-responsive supramolecular nanoparticles constructed by β-D-galactose-modified pillar [5] Arene and Camptothecin Prodrug for targeted anticancer drug delivery. Chem Commun 53:8596–8599
Liu Y, Dong T, Chen Y, Sun N, Liu Q, Huang Z, Yang Y, Cheng H, Yue K (2023) Biodegradable and cytocompatible hydrogel coating with antibacterial activity for the prevention of implant-associated infection. ACS Appl Mater Interfaces 15(9):11507–11519
Liu Y, Dong T, Chen Y, Sun N, Liu Q, Huang Z, ... Yue K (2023) Biodegradable and cytocompatible hydrogel coating with antibacterial activity for the prevention of implant-associated infection. ACS Appl Mater Interfaces 15(9):11507–11519
Lu J, Chen Y, Ding M, Fan X, Hu J, Chen Y, Li J, Li Z, Liu W (2022) A 4arm-PEG macromolecule crosslinked chitosan hydrogels as antibacterial wound dressing. Carbohydr Polym 277:118871
Lu J, Chen Y, Ding M, Fan X, Hu J, Chen Y, ... Liu W (2022) A 4arm-PEG macromolecule crosslinked chitosan hydrogels as antibacterial wound dressing. Carbohydr Polym 277:118871
Manzano M, Vallet-Regí M (2010) New developments in ordered mesoporous materials for drug delivery. J Mater Chem 20:5593–5604. https://doi.org/10.1039/b922651f
Martínez-Carmona M, Gun’ko YK, Vallet-Regí M (2018) Mesoporous silica materials as drug delivery: “the nightmare” of bacterial infection. Pharmaceutics 10:279. https://doi.org/10.3390/pharmaceutics10040279
McDougald D, Rice SA, Barraud N, Steinberg PD, Kjelleberg S (2012) Should we stay or should we go: mechanisms and ecological consequences for biofilm dispersal. Nat Rev Microbiol 10:39–50
Mebert AM, Aimé C, Alvarez GS et al (2016) Silica core-shell particles for the dual delivery of gentamicin and rifamycin antibiotics. J Mater Chem B 4(18):3135–3144. https://doi.org/10.1039/c6tb00281a
Mekaru H, Lu J, Tamanoi F (2015) Development of mesoporous silica-based nanoparticles with controlled release capability for cancer therapy. Adv Drug Deliv Rev 95:40–49
Mirsaeidi SM, Tabarsi P, Khoshnood K, Pooramiri MV, Rowhani-Rahbar A, Mansoori SD, Masjedi H, Zahirifard S, Mohammadi F, Farnia P, Masjedi MR, Velayati AA (2005) Treatment of multiple drug-resistant tuberculosis (MDR-TB) in Iran. Int J Infect Dis 9:317–322
Mirzajani F, Ghassempour A, Aliahmadi A, Esmaeili MA (2011) Antibacterial effect of silver nanoparticles on Staphylococcus aureus. Res Microbiol 162(5):542–549. https://doi.org/10.1016/j.resmic.2011.04.009
Montalvo-Quirós S, Gómez-Graña S, Vallet-Regí M, Prados- Rosales RC, González B, Luque-Garcia JL (2021) Mesoporous silica nanoparticles containing silver as novel antimycobacterial agents against Mycobacterium tuberculosis. Colloids Surf B Biointerfaces 197:111405. https://doi.org/10.1016/j.colsurfb.2020.111405
Moser M, Nirmalananthan N, Behnke T, Geißler D, ReschGenger U (2018) Multimodal cleavable reporters versus conventional labels for optical quantification of accessible amino and carboxy groups on nano- and microparticles. Anal Chem 90:5887–5895
Mudakavi RJ, Raichur AM, Chakravortty D (2014) Lipid coated mesoporous silica nanoparticles as an oral delivery system for targeting and treatment of intravacuolar Salmonella infections. RSC Adv 4(105):61160–61166. https://doi.org/10.1039/c4ra12973c
Nadell CD, Drescher K, Foster KR (2016) Spatial structure, cooperation and competition in biofilms. Nat Rev Microbiol 14:589–600
Nguyen TK, Duong HT, Selvanayagam R, Boyer C, Barraud N (2015) Iron oxide nanoparticle-mediated hyperthermia stimulates dispersal in bacterial biofilms and enhances antibiotic efficacy. Sci Rep 5:18385
Pan QS, Chen TT, Nie CP, Yi JT, Liu C, Hu YL, Chu X (2018) In situ synthesis of ultrathin ZIF-8 film-coated MSNs for codelivering Bcl2 SiRNA and doxorubicin to enhance chemotherapeutic efficacy in drug-resistant cancer cells. ACS Appl Mater Interfaces 10:33070–33077
Parham S, Wicaksono DHB, Bagherbaigi S, Lee SL, Nur H (2016) Antimicrobial treatment of different metal oxide nanoparticles: a critical review. J Chinese Chem Soc 63(4):385–393. https://doi.org/10.1002/jccs.201500446
Park J, Kim J, Singha K, Han DK, Park H, Kim WJ (2013) Nitric oxide integrated polyethylenimine-based tri-block copolymer for efficient antibacterial activity. Biomaterials 34:8766–8775
Pedraza D, Díez J, Barba II, Colilla M, Vallet-Regi M (2018) Amine- functionalized mesoporous silica nanoparticles: a new nanoantibiotic for bone infection treatment. Biomed Glas 4(1):1–12. https://doi.org/10.1515/bglass-2018-0001
Phillips E, Penate-Medina O, Zanzonico PB, Carvajal RD, Mohan P, Ye Y, ... Bradbury MS (2014) Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe. Sci Transl Med 6(260):260ra149–260ra149
Pugazhendhi A, Prabakar D, Jacob JM, Karuppusamy I, Saratale RG (2018) Synthesis and characterization of silver nanoparticles using Gelidium amansii and its antimicrobial property against various pathogenic bacteria. Microb Pathog 114:41–45. https://doi.org/10.1016/j.micpath.2017.11.013
Pun SH, Bellocq NC, Liu A, Jensen G, Machemer T, Quijano E, Schluep T, Wen S, Engler H, Heidel J, Davis ME (2004) Cyclodextrin-modified polyethylenimine polymers for gene delivery. Bioconjug Chem 15:831–840
Quan K, Zhang Z, Chen H, Ren X, Ren Y, Peterson BW, van der Mei HC, Busscher HJ (2019) Artificial channels in an infectious biofilm created by magnetic nanoparticles enhanced bacterial killing by antibiotics. Small 15:1902313
Ramon-García S, Ng C, Anderson H, Chao JD, Zheng X, Pfeifer T, Av-Gay Y, Roberge M, Thompson CJ (2011) Synergistic drug combinations for tuberculosis therapy identified by a novel high throughput screen. Antimicrob Agents Chemother 55:3861–3869
Ray S, Cheng CA, Chen W, Li Z, Zink JI, Lin YY (2019) Magnetic heating stimulated cargo release with dose control using multifunctional MR and thermosensitive liposome. Nanotheranostics 3:166–178
Roemer T, Boone C (2013) Systems-level antimicrobial drug and drug synergy discovery. Nat Chem Biol 9:222–231
Salomoni R, Léo P, Montemor A, Rinaldi B, Rodrigues M (2017) Antibacterial effect of silver nanoparticles in Pseudomonas aeruginosa. Nanotechnol Sci Appl 10:115–121. https://doi.org/10.2147/NSA.S133415
Sanchez-Salcedo S, Vallet-Regí M, Shahin SA, Glackin CA, Zink JI (2018) Mesoporous core-shell silica nanoparticles with anti-fouling properties for ovarian cancer therapy. Chem Eng J 340:114–124. https://doi.org/10.1016/j.cej.2017.12.116
Saqib S, Munis MFH, Zaman W et al (2019) Synthesis, characterization and use of iron oxide nano particles for antibacterial activity. Microsc Res Tech 82(4):415–420. https://doi.org/10.1002/jemt.23182
Saravanakumar G, Kim J, Kim WJ (2017) Reactive-oxygen-species responsive drug delivery systems: promises and challenges. Adv Sci 4:1600124
Selvarajan V, Obuobi S, Ee PLR (2020) Silica nanoparticles-a versatile tool for the treatment of bacterial infections. Front Chem 8:602. https://doi.org/10.3389/fchem.2020.00602
Shen J, Kim HC, Su H, Wang F, Wolfram J, Kirui D, Mai J, Mu C, Ji L, Mao Z, Shen H (2014) Cyclodextrin and polyethylenimine functionalized mesoporous silica nanoparticles for delivery of siRNA cancer therapeutics. Theranostics 4:487
Smith AW (2005) Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems? Adv Drug Deliv Rev 57:1539–1550
Song H, Ahmad Nor Y, Yu M et al (2016) Silica nanopollens enhance adhesion for long-term bacterial inhibition. J Am Chem Soc 138(20):6455–6462. https://doi.org/10.1021/jacs.6b00243
Song Y, Cai L, Tian Z, Wu Y (2020) Phytochemical Curcumin- Coformulated CJ. Silver-decorated melanin-like polydopamine/ mesoporous silica composites with improved antibacterial and chemotherapeutic effects against drug-resistant cancer cells. ACS Omega 5(25):15083–15094. https://doi.org/10.1021/acsomega.0c00912
Stacy A, McNally L, Darch SE, Brown SP, Whiteley M (2016) The biogeography of polymicrobial infection. Nat Rev Microbiol 14:93–105
Stewart PS, Costerton JW (2001) Antibiotic resistance of bacteria in biofilms. Lancet 358:135–138
Subbiahdoss G, Sharifi S, Grijpma DW, Laurent S, van der Mei HC, Mahmoudi M, Busscher HJ (2012) Magnetic targeting of surface-modified superparamagnetic iron oxide nanoparticles yields antibacterial efficacy against biofilms of gentamicin-resistant Staphylococci. Acta Biomater 8:2047–2055
Tasia W, Lei C, Cao Y, Ye Q, He Y, Xu C (2020) Enhanced eradication of bacterial biofilms with DNase I-loaded silver-doped mesoporous silica nanoparticles. Nanoscale 12(4):2328–2332. https://doi.org/10.1039/c9nr08467c
Taylor EN, Kummer KM, Durmus NG, Leuba K, Tarquinio KM, Webster TJ (2012) Superparamagnetic iron oxide nanoparticles (SPION) for the treatment of antibiotic-resistant biofilms. Small 8:3016–3027
Tenland E, Pochert A, Krishnan N et al (2019) Effective delivery of the anti-mycobacterial peptide NZX in mesoporous silica nanoparticles. PLoS ONE 14(2):1–16. https://doi.org/10.1371/journal.pone.0212858
Thomas CR, Ferris DP, Lee JH, Choi E, Cho MH, Kim ES, Stoddart JF, Shin J-S, Cheon J, Zink JI (2010) Noninvasive remote-controlled release of drug molecules in vitro using magnetic actuation of mechanized nanoparticles. J Am Chem Soc 132:10623–10625
Thurlow LR, Hanke ML, Fritz T, Angle A, Aldrich A, Williams SH, Engebretsen IL, Bayles KW, Horswill AR, Kielian T (2011) Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo. J Immunol 186:6585–6596
Tian Y, Qi J, Zhang W, Cai Q, Jiang X (2014) Facile, one-pot synthesis, and antibacterial activity of mesoporous silica nanoparticles decorated with well-dispersed silver nanoparticles. ACS Appl Mater Interfaces 6(15):12038–12045. https://doi.org/10.1021/am5026424
Torella JP, Chait R, Kishony R (2010) Optimal drug synergy in antimicrobial treatments. PLoS Comput Biol 6:e1000796
Trewyn BG, Whitman CM, Lin VSY (2004) Morphological control of room-temperature ionic liquid templated mesoporous silica nanoparticles for controlled release of antibacterial agents. Nano Lett 4(11):2139–2143. https://doi.org/10.1021/nl048774r
Vallet-Regí M, Rámila A, del Real RP, Pérez-Pariente J (2001) A new property of MCM-41: drug delivery system. Chem Mater 13:308–311. https://doi.org/10.1021/cm0011559
Vallet-Regí M, Balas F, Arcos D (2007) Mesoporous materials for drug delivery. Angew Chem Int Ed 46:7548–7558. https://doi.org/10.1002/anie.200604488
Vallet-Regí M, Colilla M, González B (2011) Medical applications of organic–inorganic hybrid materials within the field of silica-based bioceramics. Chem Soc Rev 40:596–607. https://doi.org/10.1039/C0CS00025F
Vallet-Regí M, Izquierdo-Barba I, Colilla M (2012) Structure and functionalization of mesoporous bioceramics for bone tissue regeneration and local drug delivery. Philos Trans A Math Phys Eng Sci 370:1400–1421. https://doi.org/10.1098/rsta.2011.0258
Vallet-Regí M, González B, Izquierdo-Barba I (2019) Nanomaterials as promising alternative in the infection treatment. Int J Mol Sci 20. https://doi.org/10.3390/ijms20153806
van Gennip M, Christensen LD, Alhede M, Qvortrup K, Jensen PØ, Høiby N, Givskov M, Bjarnsholt T (2012) Interactions between polymorphonuclear leukocytes and pseudomonas aeruginosa biofilms on silicone implants in vivo. Infect Immun 80:2601–2607
Velikova N, Mas N, Miguel-Romero L et al (2017) Broadening the antibacterial spectrum of histidine kinase autophosphorylation inhibitors via the use of ε-poly-L-lysine capped mesoporous silica-based nanoparticles. Nanomed Nanotechnol Biol Med 13(2):569–581. https://doi.org/10.1016/j.nano.2016.09.011
Wan X, Zhuang L, She B, Deng Y, Chen D, Tang J (2016) In-situ reduction of monodisperse nanosilver on hierarchical wrinkled mesoporous silica with radial pore channels and its antibacterial performance. Mater Sci Eng C 65:323–330. https://doi.org/10.1016/j.msec.2016.04.058
Wang Y, Zhao Q, Han N, Bai L, Li J, Liu J, Che E, Hu L, Zhang Q, Jiang T, Wang S (2015) Mesoporous silica nanoparticles in drug delivery and biomedical applications. Nanomedicine 11:313–327
Wang Y, Ding X, Chen Y et al (2016) Antibiotic-loaded, silver core-embedded mesoporous silica nanovehicles as a synergistic antibacterial agent for the treatment of drug-resistant infections. Biomaterials 101:207–216. https://doi.org/10.1016/j.biomaterials.2016.06.004
Wang Y, Nor YA, Song H et al (2016) Small-sized and large-pore dendritic mesoporous silica nanoparticles enhance antimicrobial enzyme delivery. J Mater Chem B 4(15):2646–2653. https://doi.org/10.1039/C6TB00053C
Wang X, Shi L, Zhang J, Cheng J, Wang X (2017) Self-assembly fabrication, microstructures and antibacterial performance of layer-structured montmorillonite nanocomposites with cationic silica nanoparticles. RSC Adv 7(50):31502–31511. https://doi.org/10.1039/c7ra04353h
Wang X, Wu J, Li P, Wang L, Zhou J, Zhang G, Li X, Hu B, Xing X (2018) Microenvironment-responsive magnetic nanocomposites based on silver nanoparticles/gentamicin for enhanced biofilm disruption by magnetic field. ACS Appl Mater Interfaces 10:34905–34915
Wang S, Liu X, Chen S, Liu Z, Zhang X, Liang XJ, Li L (2019) Regulation of Ca2+ signaling for drug-resistant breast cancer therapy with mesoporous silica nanocapsule encapsulated doxorubicin/siRNA cocktail. ACS Nano 13:274–283
Wen J, Yang K, Liu F, Li H, Xu Y, Sun S (2017) Diverse gatekeepers for mesoporous silica nanoparticle based drug delivery systems. Chem Soc Rev 46:6024–6045
Wu H, Jin H, Wang C, Zhang Z, Ruan H, Sun L, Yang C, Li Y, Qin W, Wang C (2017) Synergistic cisplatin/doxorubicin combination chemotherapy for multidrug-resistant cancer via polymeric nanogels targeting delivery. ACS Appl Mater Interfaces 9:9426–9436
Xia J, Li Y, He C, Yong C, Wang L, Fu H, He XL, Wang ZY, Liu DF, Zhang YY (2023) Synthesis and biological activities of oxazolidinone pleuromutilin derivatives as a potent anti-MRSA agent. ACS Infect Dis 9(9):1711–1729
Xia J, Li Y, He C, Yong C, Wang L, Fu H, ... Zhang YY (2023) Synthesis and biological activities of oxazolidinone pleuromutilin derivatives as a potent anti-MRSA agent. ACS Infect Dis 9(9):1711–1729
Xu C, He Y, Li Z, Ahmad Nor Y, Ye Q (2018) Nanoengineered hollow mesoporous silica nanoparticles for the delivery of antimicrobial proteins into biofilms. J Mater Chem B 6(13):1899–1902. https://doi.org/10.1039/C7TB03201C
Xu JW, Yao K, Xu ZK (2019) Nanomaterials with a photothermal effect for antibacterial activities: an overview. Nanoscale 11(18):8680–8691. https://doi.org/10.1039/c9nr01833f
Yang Y, Jia X, Zhang YM, Li N, Liu Y (2018) Supramolecular nanoparticles based on β-CD modified hyaluronic acid for DNA encapsulation and controlled release. Chem Commun 54:8713–8716
Yang S, Han X, Yang Y et al (2018) Bacteria-targeting nanoparticles with microenvironment-responsive antibiotic release to eliminate intracellular staphylococcus aureus and associated infection. ACS Appl Mater Interfaces 10(17):14299–14311. https://doi.org/10.1021/acsami.7b15678
Yin IX, Zhang J, Zhao IS, Mei ML, Li Q, Chu CH (2020) The antibacterial mechanism of silver nanoparticles and its application in dentistry. Int J Nanomed 15:2555–2562. https://doi.org/10.2147/IJN.S246764
Yu Q, Deng T, Lin FC, Zhang B, Zink JI (2020) Supramolecular assemblies of heterogeneous mesoporous silica nanoparticles to co-deliver antimicrobial peptides and antibiotics for synergistic eradication of pathogenic biofilms. ACS Nano 14(5):5926–5937. https://doi.org/10.1021/acsnano.0c01336
Yu P, Wang Z, Marcos-Hernandez M, Zuo P, Zhang D, Powell C, Pan AY, Villagran D, Wong MS, Alvarez PJ (2019) BottomUp biofilm eradication using bacteriophage-loaded magnetic nanocomposites: a computational and experimental study. Environ Sci Nano 6:3539−3550
Zhang C, Du C, Liao JY, Gu Y, Gong Y, Pei J, Gu H, Yin D, Gao L, Pan Y (2019) Synthesis of magnetite hybrid nanocomplexes to eliminate bacteria and enhance biofilm disruption. Biomater Sci 7:2833–2840
Author information
Authors and Affiliations
Contributions
All the authors have contributed equally. The authors confirm that no paper mill and artificial intelligence was used.
Corresponding author
Ethics declarations
Ethical approval
Not applicable.
Consent to participate
All authors have their consent to participate.
Consent for publication
All authors have their consent to publish their work.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sil, M., Mukherjee, D., Goswami, A. et al. Antibiofilm activity of mesoporous silica nanoparticles against the biofilm associated infections. Naunyn-Schmiedeberg's Arch Pharmacol 397, 3617–3633 (2024). https://doi.org/10.1007/s00210-023-02872-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-023-02872-0